Thermo Fisher Scientific | TMO - Selling And Administration Expenses


Thermo Fisher Scientific reported $1.86B in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Agilent USD 475M 10M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
Bruker USD 238.9M 3.2M Jun/2026
Charles River Laboratories USD 228.9M 69.47M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 364M 13M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
General Electric Aerospace USD 1.09B 40M Sep/2026
Henry Schein USD 831M 22M Jun/2026
Illumina USD 273M 1000K Jun/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
IQVIA Holdings USD 574M 72M Jun/2026
Laboratory Of America USD 577.2M 26.2M Jun/2026
Medtronic 3.2B 141M Jun/2026
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Olympus JPY 125.03B 14.31B Jun/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quest Diagnostics USD 523M 6M Sep/2026
Repligen USD 76.62M 82K Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Veracyte USD 55.71M 4.87M Jun/2026
Waters USD 405M 11M Jun/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026